Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Deloitte
Covington
Boehringer Ingelheim
Harvard Business School
Accenture
Teva
AstraZeneca
Medtronic
Fish and Richardson

Generated: October 19, 2017

DrugPatentWatch Database Preview

CLINDAMYCIN PHOSPHATE AND TRETINOIN Drug Profile

« Back to Dashboard

What is the patent landscape for Clindamycin Phosphate And Tretinoin, and when can generic versions of Clindamycin Phosphate And Tretinoin launch?

Clindamycin Phosphate And Tretinoin is a drug marketed by Actavis Mid Atlantic and is included in one NDA.

The generic ingredient in CLINDAMYCIN PHOSPHATE AND TRETINOIN is clindamycin phosphate; tretinoin. There are fifty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.

Summary for Tradename: CLINDAMYCIN PHOSPHATE AND TRETINOIN

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list106,818
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLINDAMYCIN PHOSPHATE AND TRETINOIN at DailyMed

Pharmacology for Tradename: CLINDAMYCIN PHOSPHATE AND TRETINOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic
CLINDAMYCIN PHOSPHATE AND TRETINOIN
clindamycin phosphate; tretinoin
GEL;TOPICAL202564-001Jun 12, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Julphar
Chubb
Medtronic
Mallinckrodt
Cipla
Cerilliant
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot